Anthera Announces the Phase 3 SOLUTION Study with Sollpura™ in Cystic Fibrosis Patients with Exocrine Pancreatic Insufficiency ...
Sollpura narrowly missed the primary endpoint for change in the Coefficient of Fat Absorption (CFA) non-inferiority margin Sollpura demonstrated non-inferiority in the per protocol CFA analysis Sollpura demonstrated non-inferiority in Coefficient of …